氯鹼化工(600618.SH)與控股股東對廣西氯鹼公司增資合計13.69億元
格隆匯1月16日丨氯鹼化工(600618.SH)公佈,公司與公司控股股東上海華誼(集團)公司(“上海華誼”)按股權比例(60:40)以現金出資方式對廣西華誼氯鹼化工有限公司(“廣西氯鹼公司”)進行增資。此次增資總額為136874萬元,其中:公司增資82124.4萬元,上海華誼增資54749.6萬元。
廣西氯鹼公司增資能夠為項目的建設開發提供重要資金支持,保障項目的順利開展。該項目投資完成後,可能因為日常生產經營的需要與公司控股股東上海華誼產生新增關聯交易。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.